Molina Healthcare Inc (NYSE:MOH) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued to investors on Tuesday.

According to Zacks, “Molina Healthcare’s shares have underperformed the industry in last one year. The company suffers from rising medical care costs along with acute dependence on debt financing that have resulted in higher interest expenses draining the bottom line. Following its lackluster second-quarter 2017 results, the company also withdrew its 2017 guidance. It has seen the Zacks Consensus Estimate for the 2018 earnings being revised downward in last 60 days.”

Several other equities analysts have also recently issued reports on MOH. Deutsche Bank AG reiterated a “hold” rating and set a $72.00 target price on shares of Molina Healthcare in a research report on Wednesday, August 9th. TheStreet cut Molina Healthcare from a “b” rating to a “c” rating in a research report on Monday, August 7th. BidaskClub cut Molina Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Friday, July 28th. Mitsubishi UFJ Financial Group assumed coverage on Molina Healthcare in a research report on Thursday, September 21st. They set a “neutral” rating and a $70.00 target price on the stock. Finally, Morgan Stanley upgraded Molina Healthcare from an “underweight” rating to an “overweight” rating and boosted their target price for the stock from $65.00 to $68.00 in a research report on Thursday, August 17th. Four research analysts have rated the stock with a sell rating, nine have given a hold rating and four have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus target price of $62.25.

Shares of Molina Healthcare (NYSE MOH) traded down 0.25% during mid-day trading on Tuesday, reaching $66.85. The company’s stock had a trading volume of 293,188 shares. Molina Healthcare has a 1-year low of $42.56 and a 1-year high of $72.79. The company’s market capitalization is $3.82 billion. The company’s 50 day moving average price is $64.09 and its 200-day moving average price is $62.00.

Molina Healthcare (NYSE:MOH) last released its earnings results on Wednesday, August 2nd. The company reported ($0.01) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.86 by ($0.87). Molina Healthcare had a positive return on equity of 16.10% and a negative net margin of 1.07%. The business had revenue of $5 billion for the quarter, compared to analyst estimates of $4.88 billion. During the same quarter in the previous year, the firm posted $0.67 EPS. The business’s revenue for the quarter was up 14.7% on a year-over-year basis. Analysts predict that Molina Healthcare will post ($2.70) earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This piece of content was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece of content on another site, it was copied illegally and reposted in violation of US and international copyright laws. The legal version of this piece of content can be read at https://www.thecerbatgem.com/2017/10/05/molina-healthcare-inc-moh-rating-lowered-to-sell-at-zacks-investment-research.html.

In related news, Director J Mario Md Molina sold 15,000 shares of the company’s stock in a transaction that occurred on Tuesday, October 3rd. The stock was sold at an average price of $67.73, for a total value of $1,015,950.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director John C. Molina sold 22,400 shares of the company’s stock in a transaction that occurred on Thursday, September 28th. The shares were sold at an average price of $67.01, for a total value of $1,501,024.00. Following the completion of the sale, the director now directly owns 540,722 shares in the company, valued at approximately $36,233,781.22. The disclosure for this sale can be found here. In the last ninety days, insiders sold 293,045 shares of company stock worth $18,799,628. 6.20% of the stock is owned by corporate insiders.

A number of hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. lifted its stake in Molina Healthcare by 1.9% in the 2nd quarter. Vanguard Group Inc. now owns 3,619,435 shares of the company’s stock valued at $250,392,000 after buying an additional 66,206 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in Molina Healthcare by 12.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 2,488,977 shares of the company’s stock valued at $113,498,000 after buying an additional 282,144 shares in the last quarter. Redmile Group LLC lifted its stake in Molina Healthcare by 42.7% in the 1st quarter. Redmile Group LLC now owns 1,149,727 shares of the company’s stock valued at $52,428,000 after buying an additional 344,181 shares in the last quarter. Epoch Investment Partners Inc. lifted its stake in Molina Healthcare by 16.9% in the 1st quarter. Epoch Investment Partners Inc. now owns 923,361 shares of the company’s stock valued at $42,105,000 after buying an additional 133,412 shares in the last quarter. Finally, Northern Trust Corp lifted its stake in Molina Healthcare by 14.5% in the 2nd quarter. Northern Trust Corp now owns 900,946 shares of the company’s stock valued at $62,328,000 after buying an additional 113,808 shares in the last quarter. 96.04% of the stock is currently owned by hedge funds and other institutional investors.

About Molina Healthcare

Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.

Analyst Recommendations for Molina Healthcare (NYSE:MOH)

Receive News & Stock Ratings for Molina Healthcare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare Inc and related stocks with our FREE daily email newsletter.